Tailoring CAR T cell technology for T cell leukemia

dc.contributor.authorSchorr, Christopher
dc.contributor.authorPerna, Fabiana
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-06-26T17:16:29Z
dc.date.available2024-06-26T17:16:29Z
dc.date.issued2023
dc.eprint.versionFinal published version
dc.identifier.citationSchorr C, Perna F. Tailoring CAR T cell technology for T cell leukemia. Mol Ther. 2023;31(3):603-604. doi:10.1016/j.ymthe.2023.02.006
dc.identifier.urihttps://hdl.handle.net/1805/41929
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.ymthe.2023.02.006
dc.relation.journalMolecular Therapy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectAdoptive immunotherapy
dc.subjectT-cell leukemia
dc.subjectChimeric antigen receptors
dc.titleTailoring CAR T cell technology for T cell leukemia
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014257/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Schorr2023Tailoring-PP.pdf
Size:
167.86 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: